Alzheimer's disease pathology research company AlzPath and Quanterix expand a strategic licensing agreement to advance the next generation of Alzheimer's disease biomarkers research.

Zhitongcaijing · 2d ago
Alzheimer's disease pathology research company AlzPath and Quanterix expand a strategic licensing agreement to advance the next generation of Alzheimer's disease biomarkers research.